Nuzenio

Cadrenal Therapeutics Inc

Cadrenal Therapeutics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Cadrenal Therapeutics (CVKD): PNC discloses 8.13% beneficial stake for client - stocktitan.netstocktitan.net · Fri, 07 Aug 2026 17:04:02 GMT Cadrenal Therapeutics Inc (CVKD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMT CVKD | Cadrenal Therapeutics, Inc. Common Executive Compensation - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 00:09:18 GMT Cadrenal Therapeutics, Inc. SEC Filing (Aug 3, 2026) - stocktitan.netstocktitan.net · Mon, 03 Aug 2026 21:14:31 GMT CVKD: Positive CAD-1005 Data Accelerates Transition Toward Business Development Strategy - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 16:15:00 GMT Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:30:00 GMT CAD-1005 Phase 2 Data Show >25% Absolute Reduction in Thrombotic Events - stocktitan.netstocktitan.net · Mon, 03 Aug 2026 12:30:00 GMT Cadrenal Therapeutics announces annual shareholder meeting - BitgetBitget · Mon, 03 Aug 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 17:04:02 GMTCadrenal Therapeutics (CVKD): PNC discloses 8.13% beneficial stake for client - stocktitan.net

Thu, 06 Aug 2026 07:00:00 GMTCadrenal Therapeutics Inc (CVKD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Thu, 06 Aug 2026 00:09:18 GMTCVKD | Cadrenal Therapeutics, Inc. Common Executive Compensation - Quiver Quantitative

Mon, 03 Aug 2026 21:14:31 GMTCadrenal Therapeutics, Inc. SEC Filing (Aug 3, 2026) - stocktitan.net

Mon, 03 Aug 2026 16:15:00 GMTCVKD: Positive CAD-1005 Data Accelerates Transition Toward Business Development Strategy - Yahoo Finance

Mon, 03 Aug 2026 12:30:00 GMTCadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

CVKD8 live mentions Cadrenal Therapeutics7 live mentions Inc6 live mentions CAD4 live mentions Phase4 live mentions PNC2 live mentions Earnings Forecast2 live mentions Future EPS2 live mentions Revenue Growth Estimates2 live mentions TradingKey Cadrenal Therapeutics2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cadrenal Therapeutics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.